Solana price reclaimed $75 on Friday, extending its December gains to 20%. A vital on-chain metric suggests that SOL could now shoot for the $100 target.
In March 2025, BiomX announced positive topline results of the phase 2 trial evaluating BX211 for the treatment of diabetic...
HONG KONG, May 15, 2025 (GLOBE NEWSWIRE) -- CoinEx Charity has successfully implemented its global humanitarian initiative, “Bridge to Hope,”...
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a...
First Patient Enrolled in Multi-Dose Phase 1b/2 Trial of Bel-sar in Non-Muscle-Invasive Bladder Cancer (NMIBC); Initial Data at 3 Months...
HONOLULU, May 15, 2025 (GLOBE NEWSWIRE) -- Barnwell Industries, Inc. (NYSE American: BRN) today reported financial results for its second...
CALGARY, Alberta, May 15, 2025 (GLOBE NEWSWIRE) -- Calfrac Well Services Ltd. (“Calfrac” or “the Company”) (TSX: CFW) announces its...
